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of mammalian cancers, but they'now appear to play central biological roles in other eucaryotes as well. Because genetic manipulations can be performed with relative ease in the yeast Saccharomyces cerevisiae, the most rapid advances in our knowledge of the RAS gene function come from studies of this organism. Studies of the RAS genes in S. cerevisiae have provided important information about the control of cell growth in yeasts, information which may be relevant to the function of the ras gene in mammalian cells as well.
ras genes were originally identified as those responsible for the transforming ability of Harvey and Kirsten murine sarcoma viruses (reviewed in reference 12). These helperdependent retroviruses induce tumors in mice after a short latent period, usually 2 to 3 weeks. The transforming genes present in the viruses code for similar 21,000-dalton proteins, termed p21. Independent experiments have revealed that human tumors contain DNA sequences capable of transforming mouse fibroblast NIH 3T3 cells. Cloning of these sequences has indicated that many are cellular homologs of the viral ras genes. Three distinct genes have been identified in this manner: two genes closely related to viral Harvey and Kirsten ras (cHa-ras and cKi-ras) (11, 28, 31) and a third gene with no viral counterpart (N-ras) (34) . All three genes code for closely related proteins, with less than 20% amino acid divergence among members of the family.
Transforming ras genes, whether of viral or cellular origin, differ from their normal cellular homologs by the presence of missense mutations at a limited number of positions. Mutations at amino acid positions 12, 13, 59, 61, and 63 are sufficient to confer a transforming phenotype (13, 32 , and references therein). The observation that these missense mutations reduce the intrinsic GTPase activity of p21 (16, 26, 36, 42) (46) .
The GTPase specific activity of p21 is similar to that of a number of G proteins including the GTP-binding proteins of signal transduction systems (17, 35) and bacterial elongation factor EF-Tu (18) . This similarity between p21 and the G proteins of the signal transduction pathway, the fact that the ras-encoded transforming proteins are domninant in heterozygous diploid cells, and the cell surface location of p21 (37, 42) . Mutations analogous to those that give transforming ability to p21 decrease this GTPase activity (37, 42) .
These structural and biochemical similarities provide compelling evidence that the mammalian and yeast ras genes are related but by no means prove that they carry out the same function. As described below, the yeast RAS genes are essential for cell growth. However, yeast strains lacking both RAS genes are viable if they contain either the normal mammalian or viral Ha-ras genes (10, 20) . Conversely, a modified yeast RASJ gene, containing a valine codon at position 19 and an in-frame deletion removing the nonhomologous region near the C terminus, will transform NIH 3T3 cells (10) . Thus, ras genes from S. cerevisiae and mammals are functionally homologous and could carry out the same function in both organisms.
The first clue as to the function of the RAS genes in S. cerevisiae came from gene disruption experiments. In a now almost routine experiment, cloned RAS genes were made nonfunctional by inserting fragments of DNA coding for selectable markers into the middle of the RAS coding sequence. These disrupted genes were reintroduced into S. cerevisiae so that the disrupted allele replaced the wild type. These experiments indicate that RAS] and RAS2 are members of an essential gene family. Strains lacking either a functional RAS] or RAS2 are viable, but spores with disruptions in both genes either fail to germinate or growth is arrested after germination but before the formation of the first bud (21, 39) . The growth of yeast strains that contain, as their sole RAS gene, a gene under the control of an inducible promoter, is arrested when the RAS gene is not induced, resulting in populations of unbudded, nongrowing cells (20) . The growth of strains with temperature-sensitive RAS alleles is also arrested in Gl at the restrictive temperature (J. Broach, personal communication). This terminal phenotype, arrested cell cycle development in Gl, characterized by unbudded, nongrowing cells, is shared by a class of temperature-sensitive cell division cycle mutations (cdc19, cdc25, cdc33, and cdc35) and by nutritionally arrested, wild-type cells (30) . The RAS gene therefore appears to be required either for growth or passage through the cell cycle. This evidence alone does not indicate that the RAS gene plays a key or pivitol role in cell growth control, because any number of metabolic blocks might cause a similar Gl arrest phenotype. For example, one member of this class of mutations, cdcl9, is the structural gene for pyruvate kinase (G. Kawasaki, Ph.D. thesis, University of Washington, Seattle, 1979). The RAS gene could encode an enzyme, in any number of metabolic pathways, that is no more or no less interesting than pyruvate kinase. However, additional observations suggest that the RAS gene does indeed have a regulatory role in controlling cell growth.
Yeast strains that contain a RAS2 gene with valine substituted for glycine at amino acid position 19 (analogous to the transforming-position-12 mutation in the mammalian ras gene) fail to accumulate storage carbohydrates, are unable to sporulate efficiently, and lose viability rapidly when starved (21, 43) . All of these traits are dominant to the wild-type RAS2 gene. In contrast, strains that lack RAS2 have virtually the opposite phenotype; they sporulate on rich media (normal strains of S. cerevisiae require starvation conditions to initiate the meiotic cell cycle) (40, 43) and hyperaccumulate storage carbohydrates (40) . Surprisingly, mutations in RAS] have neither of these phenotypes. The RAS]Va1I9 mutation has none of the dominant effects of the RAS2VaII9 mutation, and disruptions of RAS] which cause a loss of function create no observable phenotypic change when RAS2 is present (unpublished observations). This difference could be caused by decreased expression of the RAS] gene relative to that of the RAS2 gene or by a qualitative difference between the two genes.
The ability of RAS2 mutants to sporulate on rich media is shared by the cell division cycle mutants carrying the cdc25 and cdc351cyrl mutations (23, 33) . cyrl (allelic to cdc35) is thought to be the structural gene for adenylate cyclase. In strains that can take up cyclic AMP (cAMP), the lethality of cyri mutations can be rescued by exogenous cAMP (25) .
The growth of such strains is arrested, and they are unbudded in Gl of the cell cycle in the absence of exogenous cAMP. cyri mutants have very low levels of adenylate cyclase activity, and one allele, cdc35-10, has been reported to have temperature-sensitive adenylate cyclase activity (3). Elevated expression of the cloned CYR] gene leads to increased levels of adenylate cyclase activity in S. cerevisiae (6, 19) and Escherichia coli (19, 45) . Matsumoto et al. (25) have isolated a mutation, bcyl, which bypasses the cAMP requirement of the cyri mutation. The same mutation also bypasses the requirement for the RAS gene, allowing a cell without either RAS gene to complete the mitotic cell cycle (43) . beyl mutants have decreased levels of the regulatory subunit of the cAMP-dependent protein kinase, thereby allowing the protein kinase to function in the absence of cAMP (25) . Recent sequence analysis of the cloned BCYJ gene indicates that it likely is the structural gene for the cAMP-binding regulatory subunit (M. Wigler, personal communication).
Yeast strains with disruptions of the RAS2 gene are unable to efficiently utilize nonfermentable carbon sources such as ethanol, glycerol, or pyruvate (14, 40) . Although the nature of this gluconeogenic or respiratory defect is not fully understood, it has proven to be useful in selecting mutants that suppress the ras2 defect. In one extensive mutational analysis, five suppressor genes, termed sra for "suppressor of ras," have been identified (J. Cannon, J. Gibbs, and K. Tatchell, Genetics, in press). One recessive complementation group, sral, is allelic to bcyl and thus suppresses the ras gene by stimulating the cAMP-dependent protein kinase. SRA4 is represented by a set of dominant suppressors that are tightly linked to cyri. Adenylate cyclase activity is higher than normal in SRA4-containing strains, even in those which lack a functional ras gene. Alleles of another recessive suppressor, sra5, result in decreased levels of cAMP phosphodiesterase activity.
Mutations in bcyl and SRA4 and dominant mutations at another locus, SRA3, allow strains lacking both ras genes to grow, thus bypassing the essential requirement for ras. All three mutations also suppress the conditional lethality of recessive mutations in adenylate cyclase (cyrl/cdc35) (unpublished observations). Alleles in the recessive complementation group sra6 do not bypass deficiencies in both ras genes and do not suppress mutations in adenylate cyclase. Preliminary evidence suggests that sra6 may function by increasing the expression of RAS] on media containing only nonfermentable carbon sources since RAS] mRNA does not normally accumulate on such media (D. Brevairio, A. Hinnebusch, J. Cannon, K. Tatchell, and R. Dhar, Proc. Natl. Acad. Sci. USA, in press).
Where does the RAS gene fit in the adenylate cyclasecAMP-protein kinase pathway? S. cerevisiae contains an adenylate cyclase activity that is stimulated by GTP (7), a property shared by the mammalian adenylate cyclase. This stimulation is dependent on the RAS gene; cells without either RAS gene have almost undetectable GTP-stimulated adenylate cyclase activity, while strains containing the dominant RAS2 a1j9 mutation have increased levels of adenylate cyclase activity (43) . Mutations in adenylate cyclase activity (42) , but caution should be exerted in overinterpreting this interesting report. It is not clear whether a full-length adenylate cyclase protein was expressed in E. coli, and it is known that some cyri deletions that retain the C-terminal portion of the protein have catalytic activity (19) . Another report comes to the opposite conclusion, i.e., that the system can not be reconstituted by expressing only RAS2 and CYR] genes in E. coli (19) .
The simplest interpretation of both the genetic and biochemical data is that the RAS gene product directly stimulates adenylate cyclase in a manner analogous to the stimulation of mammalian adenylate cyclase by the G or N protein (17) . Such a function would not have been predicted for the yeast RAS gene product, based on the evidence from animal systems. Mammalian cell lines often have reduced levels of adenylate cyclase activity upon infection with ras-containing viruses (5), and p21 does not appear to activate mammalian adenylate cyclase (1) . Furthermore, the injection of RAS proteins into Xenopus oocytes does stimulate oocyte maturation but without concomitant stimulation of adenylate cyclase (2) . The high degree of homology between mammalian and yeast RAS genes suggests that the macromolecules that interact with RAS proteins, or portions thereof, are also conserved. How can this apparent paradox be resolved? The yeast adenylate cyclase gene CYR] codes for a polypeptide that contains 2,026 amino acid residues; however, only a small portion of the C terminus is required for adenylate cyclase activity (19) . If RAS protein interacts directly with adenylate cyclase, perhaps that portion of the molecule which interacts with RAS protein has a homolog in animal cells, such as a domain of another protein. This is not the only model, however. There is still no evidence that RAS protein and adenylate cyclase interact directly. The general assumption has been that RAS protein functions as a G protein, but not all of the accumulated data are consistent with such a model. In a bona fide G system, only the GTP adduct of G stimulates adenylate cyclase. However, both the GTP and the GDP-bound forms of RAS protein stimulate adenylate cyclase in the in vitro reconstitution system (4). In addition, the reconstituted adenylate cyclase system prepared from E. coli has a significantly lower level of GTP stimulation than that prepared from S. cerevisiae (45) . This suggests that adenylate cyclase activity depends on more than just CYR] and RAS gene products. The RAS gene product could be interacting with an unidentified component which, in turn, could stimulate adenylate cyclase. A more detailed biochemical and genetic analysis of the system should help resolve the apparent paradox.
Taken together, these results implicate cAMP as a key element in regulating cell growth in S. cerevisiae (reference 24 reviews these data in detail). The development of cells that lack the ability to synthesize cAMP, i.e., that contain mutations in the ras gene or adenylate cyclase, is arrested in Gl of the cell cycle, and such cells remain unbudded and nongrowing. The main function of cAMP appears to be the activation of the cAMP-dependent protein kinase, which it does by binding to the inhibitory subunit (beyl), thereby releasing the active catalytic subunit. Phosphorylation of specific substrates by this kinase leads to cell growth. This system is tuned to the nutritional state of the cell. By some unknown mechanism, depletion of essential nutrients (nitrate, sulfate, phosphate, or carbon) leads to loss of adenylate cyclase activity and consequently to decreased phosphorylation by the cAMP-dependent protein kinase. Although it has not been rigorously shown that starvation directly inhibits adenylate cyclase, it is known that the loss of a nitrate, sulfate, phosphate or carbon source leads to rapid accumulation of storage carbohydrates (22) , which are known to be regulated by the cAMP-dependent protein kinase (27, 44, 47) . Regulation of entry into the meiotic cell cycle also appears to be regulated by cAMP metabolism. Normally, sporulation is induced only by starvation conditions. However, strains with mutations causing defects in adenylate cyclase or ras activity (ras2, cdc351cyrl) sporulate on rich media. Conversely, strains that contain RAS2VaIl9, bcyl, or SRA4 mutations fail to sporulate under any conditions.
It is worth pointing out that the RAS gene and adenylate cyclase do not affect the cell cycle per se but primarily affect cell growth. Specific control of the cell cycle is regulated by another set of genes, identified by the cdc28 class of cell cycle mutations, which cause cell cycle arrest at the restrictive temperature without affecting cell growth (30) . This class of cell division cycle mutants is not suppressed by mutations that suppress the ras gene and adenylate cyclase mutations, i.e., bcyl (unpublished observations). Clearly, the systems of growth control and cell cycle control must be integrated at some point. One would expect that some signal or signals telling the cell that the necessary nutritional requirement had been met would be one of the preconditions required for cells to enter a new cell cycle. Perhaps a phosphorylation event, mediated by the cAMP-dependent protein kinase, is one such signal. The author is supported by Public Health Service grant CA37702 from the National Cancer Institute.
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